首页> 外文OA文献 >Initial Clinical and Advanced Imaging Outcomes from a Multi-Institutional Phase I Dose-Escalation Trial of RRx-001 Plus Whole Brain Radiation for Patients with Brain Metastases

【2h】

Initial Clinical and Advanced Imaging Outcomes from a Multi-Institutional Phase I Dose-Escalation Trial of RRx-001 Plus Whole Brain Radiation for Patients with Brain Metastases

机译：来自RRX-001的多机构期I剂量升级试验的初始临床和先进的成像结果加上脑转移患者的全脑辐射

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
M.M. Kim; H. Parmar; M.P. Aryal; M. Schipper; T.P. Devasia; S. Kesari; A. Morikawa; D.E. Spratt; L. Junck; J.A. Hayman; T.S. Lawrence; C. Tsien; R. Aiken; S. Goyal; S.J. Knox; S. Caroen; C. Carter; B. Oronsky; Y. Cao; C. Lao;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Initial Clinical and Advanced Imaging Outcomes from a Multi-Institutional Phase I Dose-Escalation Trial of RRx-001 Plus Whole Brain Radiation for Patients with Brain Metastases [J] . Kim M. M., Parmar H., Aryal M. P., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：来自RRX-001的多机构期I剂量升级试验的初始临床和先进的成像结果加上脑转移患者的全脑辐射
2. 505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases [J] . A.Macias, E.Neninger, E.Santiesteban, European Journal of Cancer Supplements . 2008,第12期

机译：505 POSTER抗EGFR单克隆抗体尼莫妥珠单抗联合全脑放射治疗II期临床试验的初步结果，用于诊断为晚期非小细胞肺癌不可切除的脑转移患者
3. 505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases [J] . A.Macias, E.Neninger, E.Santiesteban, European Journal of Cancer Supplements . 2008,第12期

机译：505 POSTER抗EGFR单克隆抗体尼莫妥珠单抗联合全脑放射治疗II期临床试验的初步结果，用于诊断为晚期非小细胞肺癌不可切除的脑转移患者
4. Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials [C] . Y. Xiao, F. Yin, FM S. Kong, World Congress on Medical Physics and Biomedical Engineering . 2013

机译：多机构临床试验中立体定向放射治疗（SBRT）的质量要求
5. Predicting the Clinical Outcome in Patients with Traumatic Brain Injury Using Clinical Pathway Scores [D] . Mendoza Alonzo, Jennifer L. 2013

机译：使用临床途径评分预测颅脑外伤患者的临床结果
6. CMET-46. INITIAL CLINICAL AND ADVANCED IMAGING OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I DOSE-ESCALATION TRIAL OF RRX-001 PLUS WHOLE BRAIN RADIATION FOR PATIENTS WITH BRAIN METASTASES [O] . Michelle Kim, Hemant Parmar, Madhava Aryal, -1

机译：CMET-46。多机构性阶段I的RRX-001加全脑放疗对脑转移患者的初步临床和高级影像学结果
7. BRAINSTORM: A Multi-Institutional Phase 1/2 Study of RRx-001 in Combination With Whole Brain Radiation Therapy for Patients With Brain Metastases [O] . Michelle M. Kim, Hemant A. Parmar, Matthew Schipper, 2020

机译：头脑风暴：对脑转移患者的全脑放射治疗组合rRX-001的多机构期1/2研究

Initial Clinical and Advanced Imaging Outcomes from a Multi-Institutional Phase I Dose-Escalation Trial of RRx-001 Plus Whole Brain Radiation for Patients with Brain Metastases

著录项

相似文献

相关主题

期刊订阅